SK BIOSCIENCE revenue breakdown overview

SK BIOSCIENCE revenue for the last year amounted to 267.77 B KRW, the most of which — 267.55 B KRW — came from its highest performing source at the moment, Vaccines and Biopharmaceuticals, the year earlier bringing 369.51 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought SK BIOSCIENCE 131.49 B KRW, and the year before that — 158.22 B KRW.